DNTH
#1367
Dianthus Therapeutics, Inc. - Common Stock
81.5 7 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.97%
Variación mensual
-24.72%
Variación en los últimos 6 meses
-9.64%
Cambio anual
+135.75%
Cierres anteriores
82.3 7
Open
81.7 7
Mínimo
80.9 1
Máximo
83.7 7
Financials
- Market Capitalization 4.56 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.81
Relación precio/flujo de caja
781.65
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1314 |  TVTX Travere Therapeutics, Inc. - Common Stock | 52.02 USD | -0.21% | -10.09% | -21.38% | +80.81% | 4.90 B USD | ||
| 1342 |  DFTX Definium Therapeutics, Inc. - Common Shares | 35.20 USD | -4.61% | -3.69% | -19.08% | +132.96% | 4.73 B USD | ||
| 1432 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 38.45 USD | -1.56% | -5.44% | -12.57% | +152.46% | 4.18 B USD | ||
| 1448 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.57 USD | -3.47% | -15.39% | +5.40% | +48.15% | 4.08 B USD |